CYTOKINE PROFILE IN QUADRICEPS MUSCLES OF PATIENTS WITH SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE
暂无分享,去创建一个
M. Polkey | E. Barreiro | J. Gea | A. Schols | E. B. Swallow | J. Galdiz | C. Coronell | R. Harry | Gosker
[1] E. Barreiro,et al. Upregulation of pro-inflammatory cytokines in the intercostal muscles of COPD patients , 2007, European Respiratory Journal.
[2] S. Hussain,et al. Ventilatory muscle activation and inflammation: cytokines, reactive oxygen species, and nitric oxide. , 2007, Journal of applied physiology.
[3] J. Viña,et al. Exercise-induced systemic effects in muscle-wasted patients with COPD. , 2006, Medicine and science in sports and exercise.
[4] S. Hussain,et al. Expression and carbonylation of creatine kinase in the quadriceps femoris muscles of patients with chronic obstructive pulmonary disease. , 2005, American journal of respiratory cell and molecular biology.
[5] J. D. de Sanctis,et al. Skeletal muscle inflammation and nitric oxide in patients with COPD , 2005, European Respiratory Journal.
[6] F. Maltais,et al. Hypoxaemia enhances peripheral muscle oxidative stress in chronic obstructive pulmonary disease , 2005, Thorax.
[7] F. Maltais,et al. Contractile fatigue, muscle morphometry, and blood lactate in chronic obstructive pulmonary disease. , 2005, American journal of respiratory and critical care medicine.
[8] S. Hussain,et al. Oxidative stress and respiratory muscle dysfunction in severe chronic obstructive pulmonary disease. , 2005, American journal of respiratory and critical care medicine.
[9] E. Hawe,et al. Angiotensin converting enzyme genotype and strength in chronic obstructive pulmonary disease. , 2004, American journal of respiratory and critical care medicine.
[10] G. Rallis,et al. Differential cytokine gene expression in the diaphragm in response to strenuous resistive breathing. , 2004, American journal of respiratory and critical care medicine.
[11] J. Gea,et al. Relevance of assessing quadriceps endurance in patients with COPD , 2004, European Respiratory Journal.
[12] P. Chanez,et al. Does systemic inflammation trigger local exercise-induced oxidative stress in COPD? , 2004, European Respiratory Journal.
[13] E. Wouters,et al. Tumor necrosis factor‐alpha inhibits myogenic differentiation through MyoD protein destabilization , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[14] E. Wouters,et al. Myopathological features in skeletal muscle of patients with chronic obstructive pulmonary disease , 2003, European Respiratory Journal.
[15] S. Hurd,et al. Global Strategy for the Diagnosis, Management and Prevention of COPD: 2003 update , 2003, European Respiratory Journal.
[16] J. Barberà,et al. Increased tumour necrosis factor‐α plasma levels during moderate-intensity exercise in COPD patients , 2003, European Respiratory Journal.
[17] Ruo-Pan Huang,et al. Detection of Multiple Cytokines by Protein Arrays from Cell Lysate and Tissue Lysate , 2003, Clinical chemistry and laboratory medicine.
[18] Yi-Ping Li. TNF-alpha is a mitogen in skeletal muscle. , 2003, American journal of physiology. Cell physiology.
[19] F. Maltais,et al. Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in COPD patients , 2003 .
[20] M. Luster,et al. Physiological role of tumor necrosis factor α in traumatic muscle injury , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[21] P. Blackshear,et al. Load-Dependent and -Independent Regulation of Proinflammatory Cytokine and Cytokine Receptor Gene Expression in the Adult Mammalian Heart , 2002, Circulation.
[22] Sally J. Singh,et al. Bedside methods versus dual energy X‐ray absorptiometry for body composition measurement in COPD , 2002, European Respiratory Journal.
[23] F. Maltais,et al. Lipofuscin accumulation in the vastus lateralis muscle in patients with chronic obstructive pulmonary disease , 2002, Muscle & nerve.
[24] E. Wouters,et al. Tumor necrosis factor-alpha inhibits myogenesis through redox-dependent and -independent pathways. , 2002, American journal of physiology. Cell physiology.
[25] J. Barberà,et al. Reduced muscle redox capacity after endurance training in patients with chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.
[26] R. Huang,et al. Detection of multiple proteins in an antibody-based protein microarray system. , 2001, Journal of immunological methods.
[27] X. Busquets,et al. Enhanced neutrophil response in chronic obstructive pulmonary disease , 2001, Thorax.
[28] Yi-Ping Li,et al. Cytokines and oxidative signalling in skeletal muscle. , 2001, Acta physiologica Scandinavica.
[29] A. Agustí,et al. The activity of cytochrome oxidase is increased in circulating lymphocytes of patients with chronic obstructive pulmonary disease, asthma, and chronic arthritis. , 2000, American journal of respiratory and critical care medicine.
[30] H. Saito,et al. The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.
[31] E. Wouters,et al. Altered glutamate metabolism is associated with reduced muscle glutathione levels in patients with emphysema. , 2000, American journal of respiratory and critical care medicine.
[32] N. Hopkinson,et al. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. A statement of the American Thoracic Society and European Respiratory Society. , 2009, American journal of respiratory and critical care medicine.
[33] H. Saito,et al. Circulating leptin in patients with chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.
[34] F. Maltais,et al. Chronic obstructive pulmonary disease: capillarity and fiber-type characteristics of skeletal muscle. , 1998, Journal of cardiopulmonary rehabilitation.
[35] F. Maltais,et al. Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. , 1998, Medicine and science in sports and exercise.
[36] F. Maltais,et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.
[37] E. Wouters,et al. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. , 1996, Thorax.
[38] M. Decramer,et al. Peripheral muscle weakness contributes to exercise limitation in COPD. , 1996, American journal of respiratory and critical care medicine.
[39] J. Mege,et al. Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. , 1994, American journal of respiratory and critical care medicine.
[40] E. Stadtman,et al. Carbonyl assays for determination of oxidatively modified proteins. , 1994, Methods in enzymology.
[41] J E Cotes,et al. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. , 1993, The European respiratory journal. Supplement.
[42] L. Makrides,et al. Normal standards for an incremental progressive cycle ergometer test. , 1985, The American review of respiratory disease.